The latest closing stock price for Dianthus Therapeutics as of May 14, 2025 is 18.90.
An investor who bought $1,000 worth of Dianthus Therapeutics stock at the IPO in 2018 would have $-919 today, roughly -1 times their original investment - a -30.12% compound annual growth rate over 7 years.
The all-time high Dianthus Therapeutics stock closing price was 315.20 on March 25, 2019.
The Dianthus Therapeutics 52-week high stock price is 32.27, which is 70.7% above the current share price.
The Dianthus Therapeutics 52-week low stock price is 13.37, which is 29.3% below the current share price.
The average Dianthus Therapeutics stock price for the last 52 weeks is 24.34.
An investor who bought $1,000 worth of Dianthus Therapeutics stock at the IPO in 2018 would have $-919 today, roughly -1 times their original investment - a -30.12% compound annual growth rate over 7 years.
The all-time high Dianthus Therapeutics stock closing price was 315.20 on March 25, 2019.
The Dianthus Therapeutics 52-week high stock price is 32.27, which is 70.7% above the current share price.
The Dianthus Therapeutics 52-week low stock price is 13.37, which is 29.3% below the current share price.
The average Dianthus Therapeutics stock price for the last 52 weeks is 24.34.